We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Grants First Approvals Via the Competitive Generic Therapy Pathway
FDA Grants First Approvals Via the Competitive Generic Therapy Pathway
The FDA approved drug products under the Competitive Generic Therapy (CGT) designation for the first time, granting approval to several strengths of Apotex’s potassium chloride oral solution.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor